BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9347879)

  • 21. Cell activation influences cell staining kinetics.
    Sunray M; Deutsch M; Kaufman M; Tirosh R; Weinreb A; Rachmani H
    Spectrochim Acta A Mol Biomol Spectrosc; 1997 Sep; 53A(10):1645-53. PubMed ID: 9358654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphocyte response to mitogens in serum-free and serum-containing medium in patients with rheumatoid arthritis (author's transl)].
    Smolen JS; Menzel EJ; Scherak O
    Wien Klin Wochenschr; 1978 Oct; 90(20):730-3. PubMed ID: 716428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pathogenesis of rheumatoid arthritis].
    Geiler G
    Z Gesamte Inn Med; 1980 Nov; 35(22):suppl 152-7. PubMed ID: 6451096
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of autoantigens in the driving of autoimmune diseases.
    Roitt IM
    Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescent probes to detect lymphocyte activation.
    Nairn RC; Rolland JM
    Clin Exp Immunol; 1980 Jan; 39(1):1-13. PubMed ID: 6156040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence polarization immunoassay: detection of antibody to Brucella abortus.
    Nielsen K; Lin M; Gall D; Jolley M
    Methods; 2000 Sep; 22(1):71-6. PubMed ID: 11020320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes.
    Plater-Zyberk C; Clarke MF; Lam K; Mumford PA; Room GR; Maini RN
    Clin Exp Immunol; 1983 Jun; 52(3):505-11. PubMed ID: 6603295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte nucleolar activation as a marker of autoimmune disorders. II. Observations in patients with systemic lupus erythematosus and other connective tissue diseases.
    Korcákova L; Pekárek J; Rovenský J; Trnavský K; Lukác J; Haskova V
    Immunology; 1976 Nov; 31(5):803-5. PubMed ID: 992713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cellular fluidity of peripheral blood lymphocytes from patients with urogenital cancers by a fluorescence polarization technique: PHA response and prognosis.
    Sakamoto S; Maeda H; Yamasaki K; Aikawa S; Hinuma Y
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1105-15. PubMed ID: 7200019
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular theology, immunophilosophy, and autoimmune disease. II. Speculation on the aetiology and pathogenesis of rheumatoid arthritis.
    Fudenberg HH
    Scand J Immunol; 1980; 12(6):459-65. PubMed ID: 6264588
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current status of the immunobiological disorders of rheumatoid polyarthritis. Their involvement in the genesis of the rheumatoid process].
    Barceló P (S) ; Barceló P (Jr)
    Rev Esp Reum Enferm Osteoartic; 1974; 17(4):265-340. PubMed ID: 4616294
    [No Abstract]   [Full Text] [Related]  

  • 33. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a static fluorescence-based cytometer: the CellScan in clinical immunology.
    Szyper-Kravitz M; Harel M; Gilburd B; Trubniykov E; Schiffenbauer YS; Shoenfeld Y
    Lupus; 2006; 15(7):436-41. PubMed ID: 16898179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG subclasses in rheumatoid joint disorders.
    Stanworth DR
    Monogr Allergy; 1986; 19():188-97. PubMed ID: 3762545
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 37. Idiotypic network: possible explanation of seronegativity in a patient with rheumatoid arthritis.
    Pasquali JL; Urlacher A; Storck D
    Clin Exp Immunol; 1984 Feb; 55(2):281-6. PubMed ID: 6697565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans.
    Iwakura Y; Saijo S; Kioka Y; Nakayama-Yamada J; Itagaki K; Tosu M; Asano M; Kanai Y; Kakimoto K
    J Immunol; 1995 Aug; 155(3):1588-98. PubMed ID: 7636219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of lymphocyte populations and their mitogenic activity in relation to serum copper and immunoglobulin levels in rheumatoid arthritis.
    Attia WM; Clark HW; Brown TM
    Ann Allergy; 1981 Aug; 47(2):99-103. PubMed ID: 7258747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoregulatory role of stress mediators in rheumatoid arthritis.
    Kumar R; Singh LM; Vaidya MP
    Z Rheumatol; 1981; 40(3):122-5. PubMed ID: 7282110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.